Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153829 | SCV000203410 | likely benign | not specified | 2014-11-22 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000153829 | SCV000248700 | likely benign | not specified | 2017-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000487974 | SCV000514395 | likely benign | not provided | 2020-10-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000487974 | SCV000575530 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | RELN: BP4, BS2 |
Invitae | RCV001080109 | SCV000656298 | benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001158969 | SCV001320645 | uncertain significance | Norman-Roberts syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Clinical Genetics, |
RCV000487974 | SCV001921758 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000487974 | SCV001928337 | likely benign | not provided | no assertion criteria provided | clinical testing |